Observed evidence for guideline-recommended genes in predicting prostate cancer risk from a large population-based cohort.

Germline testing for prostate cancer (PCa) is now recommended by the National Comprehensive Cancer Network. While multi-gene testing has been proposed, evidence for their association with PCa risk is not well established.